Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages S Krishnan, Y Ding, N Saedi, M Choi, GV Sridharan, DH Sherr, ... Cell reports 23 (4), 1099-1111, 2018 | 500 | 2018 |
Pathways and functions of gut microbiota metabolism impacting host physiology S Krishnan, N Alden, K Lee Current opinion in biotechnology 36, 137-145, 2015 | 188 | 2015 |
Biologically consistent annotation of metabolomics data N Alden, S Krishnan, V Porokhin, R Raju, K McElearney, A Gilbert, K Lee Analytical chemistry 89 (24), 13097-13104, 2017 | 51 | 2017 |
Advanced MRI of liver fibrosis and treatment response in a rat model of nonalcoholic steatohepatitis IY Zhou, V Clavijo Jordan, NJ Rotile, E Akam, S Krishnan, G Arora, ... Radiology 296 (1), 67-75, 2020 | 20 | 2020 |
THU-093-The calpain inhibitor, BLD-2660, has robust anti-fibrotic activity in a rat model of non-alcoholic steatohepatitis M Sojoodi, S Krishnan, AA Razavi, MR Day, G Arora, S Goshal, S Li, ... Journal of Hepatology 70 (1), e201-e202, 2019 | 4 | 2019 |
Microbiota metabolites derived from tryptophan modulate macrophage inflammation and migration through AMP-activated protein kinase Y Ding, S Krishnan, RC Alaniz, K Lee, A Jayaraman The Journal of Immunology 200 (1_Supplement), 53.18-53.18, 2018 | 1 | 2018 |
Gut Microbiota Metabolites Modulate Inflammation in Non-Alcoholic Fatty Liver Disease S Krishnan Tufts University, 2018 | 1 | 2018 |
Erratum: Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages (Cell Reports (2018) 23 (4)(1099–1111),(S2211124718304856 … S Krishnan, Y Ding, N Saeidi, M Choi, GV Sridharan, DH Sherr, ... Cell Reports 28 (12), 3285, 2019 | | 2019 |
THU-084-A comparative study of anti-Fibrotic therapeutics using aptamer-based quantitative proteomics in a rat model of non-alcoholic steatohepatitis cirrhosis S Krishnan, S Goshal, S Dillon, R Masia, D Ferreira, P Caravan, Y Li, ... Journal of Hepatology 70 (1), e196-e197, 2019 | | 2019 |
Microbiota metabolites derived from tryptophan modulate macrophage inflammation and migration in non-alcoholic fatty liver disease Y Ding, S Krishnan, K Lee, A Jayaraman The Journal of Immunology 198 (1_Supplement), 197.14-197.14, 2017 | | 2017 |
Understanding and overcoming process insults through application of ‘omics technologies A Gilbert, K McElearney, S Krishnan, N Alden, WI Yang, K Lee, ... | | 2016 |
Identification of gut microbiota-derived metabolites as liver inflammation modulators in non-alcoholic fatty liver disease S Krishnan, M Choi, Y Ding, N Saedi, ML Yarmush, A Jayaraman, K Lee Food, Pharmaceutical and Bioengineering Division 2015-Core Programming Area …, 2015 | | 2015 |
13C Metabolic Flux Analysis to Study the Effect of Oxygen on Cellular Metabolism of A549 and HeLa Cell Lines S Krishnan Johns Hopkins University, 2013 | | 2013 |
MRI Relaxometry in a Rat Model of Nonalcoholic Steatohepatitis (NASH) IY Zhou, N Rotile, VC Jordan, G Arora, S Krishnan, H Slattery, N Warner, ... | | |
Multi-Parametric MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis (NASH) IY Zhou, VC Jordan, N Rotile, S Krishnan, H Krishnan, G Arora, H Slattery, ... | | |
Imaging response to Elafibranor treatment in a rat model of non-alcoholic steatohepatitis non-invasively by oxidized-collagen molecular MRI VC Jordan, IY Zhou, N Rotile, N Warner, EA Akam, G Arora, S Krishnan, ... | | |